SK hynix
SKHY
178.25
-4.31
-2.36%
SK hynix
US · SKHY
#13 by market cap
Listed 2026
178.25
-4.31
-2.36%
Live - 5344 symbols - heartbeat 12s ago
· 2026-10-08 08:30
Pre-market
175.51
-1.54%
After-hours
179.90
+0.92%
Overnight
177.02
-0.69%
- Market cap
- 1.30T
- P/E (TTM)i
- 23.16
- P/Bi
- 10.59
- EPSi
- 4.40
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on SKHY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.52, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +46.76% YoY
Margins
- Gross margin
- 60.41%
- Operating margin
- 48.59%
- Net margin
- 44.18%
Key ratios & quality
- Enterprise valuei
- -11.04T
- PEG ratioi
- 0.14
- Altman Z-Scorei
- 2.52
PEG uses trailing P/E against the 3-year net income growth rate (168.01%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 40.45T | 26.99T | 31.90T | 43.00T | 44.62T | 32.77T | 66.19T | 97.15T |
| Gross profit | 25.26T | 8.17T | 10.81T | 18.95T | 15.63T | -533.45B | 31.83T | 58.69T |
| Selling & admin expenses | 779.58B | 920.28B | 927.78B | 1.15T | 2.20T | 1.69T | 1.73T | 1.92T |
| Research & development | 2.28T | 2.86T | 3.11T | 3.55T | 4.47T | 3.75T | 4.44T | 6.47T |
| Operating profit | 20.84T | 2.72T | 5.01T | 12.41T | 6.81T | -7.73T | 23.47T | 47.21T |
| Pretax profit | 21.34T | 2.43T | 6.24T | 13.42T | 4.00T | -11.66T | 23.89T | 50.47T |
| Tax | 5.80T | 423.56B | 1.48T | 3.80T | 1.76T | -2.52T | 4.09T | 7.52T |
| Net profit | 15.54T | 2.01T | 4.76T | 9.62T | 2.24T | -9.14T | 19.80T | 42.95T |
| Basic EPS | 2.23K | 293 | 695 | 1.40K | 324 | -1.32K | 2.87K | 6.20K |
| Diluted EPS | 2,225.50 | 293.20 | 695.00 | 1,398.40 | 324.20 | -1,324.40 | 2,841.90 | 6,037.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 17.64T | 22.23T | 24.45T | 32.83T | 52.58T | 79.32T |
| Gross profit | 10.10T | 11.98T | 14.03T | 22.58T | 41.68T | 65.99T |
| Selling & admin expenses | 434.12B | 547.44B | 406.72B | 528.34B | 437.26B | 569.63B |
| Research & development | 1.47T | 1.48T | 1.52T | 2.00T | 2.45T | 3.36T |
| Operating profit | 7.44T | 9.21T | 11.38T | 19.17T | 37.61T | 60.54T |
| Pretax profit | 9.30T | 8.72T | 14.79T | 17.65T | 51.62T | 122.71T |
| Tax | 1.19T | 1.73T | 2.19T | 2.41T | 11.27T | 28.79T |
| Net profit | 8.11T | 7.00T | 12.60T | 15.25T | 40.35T | 93.92T |
| Basic EPS | 1.18K | 1.01K | 1.82K | 2.19K | 5.72K | 13.21K |
| Diluted EPS | 1,141.10 | 958.00 | 1,785.00 | 2,152.80 | 5,667.00 | 13,147.80 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 19.89T | 14.46T | 16.57T | 26.91T | 28.73T | 30.47T | 42.28T | 69.46T |
| Cash & ST investments | 8.37T | 3.99T | 4.95T | 8.67T | 6.41T | 9.00T | 14.20T | 35.14T |
| Inventory | 4.42T | 5.30T | 6.14T | 8.95T | 15.66T | 13.48T | 13.31T | 14.29T |
| Total assets | 63.66T | 65.25T | 71.17T | 96.35T | 103.87T | 100.33T | 119.86T | 176.11T |
| Total current liabilities | 13.03T | 7.96T | 9.07T | 14.74T | 19.84T | 21.01T | 24.97T | 37.38T |
| Short-term debt | 1.61T | 3.03T | 3.46T | 3.18T | 7.70T | 10.49T | 5.84T | 8.71T |
| Long-term debt | 3.67T | 7.79T | 8.14T | 14.74T | 15.57T | 19.61T | 17.43T | 14.09T |
| Total liabilities | 16,806,004,000,000.00 | 17,312,468,000,000.00 | 19,264,756,000,000.00 | 34,155,467,000,000.00 | 40,580,970,000,000.00 | 46,826,413,000,000.00 | 45,939,505,000,000.00 | 55,440,908,000,000.00 |
| Total equity | 46.85T | 47.94T | 51.91T | 62.19T | 63.29T | 53.50T | 73.92T | 120.67T |
| Retained earnings | 41.85T | 42.92T | 47.00T | 55.78T | 56.69T | 46.73T | 65.42T | 106.58T |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 41.23T | 45.20T | 57.14T | 69.46T | 106.51T | 156.16T |
| Cash & ST investments | 14.53T | 17.09T | 28.02T | 35.14T | 54.36T | 87.98T |
| Inventory | 14.55T | 13.41T | 13.16T | 14.29T | 15.97T | 17.99T |
| Total assets | 123.99T | 129.09T | 148.44T | 176.11T | 222.83T | 348.86T |
| Total current liabilities | 24.84T | 25.32T | 29.77T | 37.38T | 40.70T | 60.26T |
| Short-term debt | 9.64T | 9.06T | 9.79T | 8.71T | 6.42T | 6.39T |
| Long-term debt | 14.25T | 13.32T | 14.83T | 14.09T | 13.43T | 12.73T |
| Total liabilities | 42,546,717,000,000.00 | 41,945,296,000,000.00 | 48,428,751,000,000.00 | 55,440,908,000,000.00 | 58,448,945,000,000.00 | 86,168,986,000,000.00 |
| Total equity | 81.44T | 87.14T | 100.01T | 120.67T | 164.38T | 262.69T |
| Retained earnings | 72.62T | 79.36T | 91.69T | 106.58T | 148.75T | 242.27T |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 22.23T | 6.55T | 12.31T | 19.80T | 14.78T | 4.28T | 29.80T | 53.37T |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 5.26T | -8.04T | 1.45T | 6.34T | -4.97T | -4.50T | 13.13T | 24.79T |
| Dividends paid | -706.00B | -1.03T | -684.00B | -805.02B | -1.68T | -825.58B | -826.32B | -1.68T |
| Stock buybacks / issuance | -1.74T | -- | -- | 8.49B | 11.67B | 24.57B | 93.83B | 65.04B |
| Ending cash balance | 2.35T | 2.31T | 2.98T | 5.06T | 4.98T | 7.59T | 11.21T | 14.92T |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 9.02T | 9.17T | 14.32T | 20.86T | 26.33T | 65.41T |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 2.57T | 4.54T | 9.06T | 8.62T | 18.46T | 54.28T |
| Dividends paid | -- | -- | -258.92B | -263.13B | -- | -- |
| Stock buybacks / issuance | 15.62B | 12.94B | 22.11B | 14.37B | 7.78B | 13.55B |
| Ending cash balance | 12.56T | 9.08T | 10.81T | 14.92T | 21.17T | 26.84T |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 38.53 | 4.25 | 9.53 | 16.84 | 3.56 | -15.61 | 31.06 | 44.15 |
| ROA %i | 28.49 | 3.13 | 6.99 | 11.46 | 2.23 | -8.92 | 17.97 | 29.00 |
| ROIC %i | 34.54 | 3.91 | 7.92 | 13.38 | 3.03 | -9.34 | 22.25 | 35.39 |
| 5-year avg ROE %i | 27.45 | 22.90 | 20.42 | 21.19 | 14.54 | 3.71 | 9.08 | 16.00 |
| EBIT margin %i | 53.00 | 9.93 | 20.35 | 31.81 | 10.17 | -31.10 | 38.12 | 52.90 |
| FCF / sales %i | 13.00 | -- | 4.53 | 14.74 | -- | -- | 19.84 | 25.52 |
| Current ratioi | 1.53 | 1.82 | 1.83 | 1.83 | 1.45 | 1.45 | 1.69 | 1.86 |
| Quick ratioi | 1.13 | 1.05 | 1.10 | 1.17 | 0.60 | 0.77 | 1.11 | 1.44 |
| Debt / assetsi | 8.30 | 18.68 | 18.12 | 19.88 | 23.87 | 32.39 | 21.24 | 14.06 |
| LT debt / equityi | 7.83 | 19.11 | 18.18 | 25.69 | 27.01 | 41.14 | 26.54 | 13.32 |
| Interest coveragei | 226.51 | 11.24 | 25.61 | 52.61 | 8.51 | -6.94 | 18.76 | 55.63 |
| Revenue CAGR (3Y) %i | 29.10 | 16.21 | 1.94 | 2.06 | 18.24 | 0.90 | 15.47 | 29.61 |
| Net income CAGR (3Y) %i | 53.20 | -12.10 | -23.55 | -14.83 | 3.59 | -- | 27.26 | 168.01 |
| FCF CAGR (3Y) %i | 39.88 | -- | -32.87 | 6.42 | -- | -- | 27.50 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 37.94 | 39.27 | 43.20 | 44.15 | 61.16 | 92.68 |
| ROA %i | 22.87 | 24.59 | 27.80 | 29.00 | 43.33 | 67.78 |
| ROIC %i | 27.29 | 29.51 | 33.42 | 35.39 | 51.34 | 82.00 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 44.83 | 46.03 | 51.58 | 52.90 | 70.88 | 109.71 |
| FCF / sales %i | 18.98 | 18.98 | 23.47 | 25.52 | 30.81 | 47.80 |
| Current ratioi | 1.66 | 1.78 | 1.92 | 1.86 | 2.62 | 2.59 |
| Quick ratioi | 1.02 | 1.20 | 1.43 | 1.44 | 2.18 | 2.26 |
| Debt / assetsi | 20.96 | 18.88 | 17.91 | 14.06 | 9.80 | 6.05 |
| LT debt / equityi | 20.07 | 17.57 | 16.80 | 13.32 | 9.38 | 5.61 |
| Interest coveragei | 26.67 | 33.49 | 44.47 | 55.63 | 112.37 | 270.57 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Manufacture and sale of semiconductor products100.00%
Quote time 2026-10-08 08:30:15 · For reference only, not investment advice and not tailored to your situation.